Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery

21 Dec 2022

Abstract excerpt

Massive efforts on both vaccine development and antiviral research were launched to combat the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We contributed, amongst others, by the development of a high-throughput screening (HTS) antiviral assay against SARS-CoV-2 using a fully automated, high-containment robot system. Here, we describe the development of this novel, convenient and phenotypic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to SARS-CoV-2 and COVID-19 Research
Share to Viral Infections and Outbreaks Research
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36565756
DOI: 10.1016/j.antiviral.2022.105506

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discoveryPMID 36565756Read ↗

A reporter cell line for the automated quantification of SARS-CoV-2 infection in living cellsSemantic proximity Read ↗

An optimized high-throughput SARS-CoV-2 dual reporter trans-complementation system for antiviral screening in vitro and in vivoSemantic proximity Read ↗

An optimized and robust SARS-CoV-2 pseudovirus system for viral entry researchSemantic proximity Read ↗

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19Semantic proximity Read ↗

A high-throughput cell-based platform for Rhinovirus C research and antiviral drug discoverySemantic proximity Read ↗

Development and characterization of recombinant tick-borne encephalitis virus expressing mCherry reporter protein: A new tool for high-throughput screening of antiviral compounds, and neutralizing antibody assaysSemantic proximity Read ↗

A versatile reporter system to monitor virus infected cells and its application to dengue virus and SARS-CoV-2Semantic proximity Read ↗

Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testingSemantic proximity Read ↗

Generation of a SARS-CoV-2 reverse genetics system and novel human lung cell lines that exhibit high virus-induced cytopathologySemantic proximity Read ↗

SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay SystemSemantic proximity Read ↗

A novel cell culture system modeling the SARS-CoV-2 life cycleSemantic proximity Read ↗

SARS-CoV-2 replicon for high-throughput antiviral screeningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.